Intellia Therapeutics Inc buy Barclays PLC
Start price
04.08.23
/
50%
€36.00
Target price
04.08.24
€81.52
Performance (%)
-40.22%
End price
05.08.24
€21.52
Summary
This prediction ended on 05.08.24 with a price of €21.52. Massive losses of -40.22% were the result for the BUY prediction by Barclays_PLC. Barclays_PLC has a follow-up prediction for Intellia Therapeutics Inc where he still thinks Intellia Therapeutics Inc is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | 0.602% | 0.602% | 33.440% |
| iShares Core DAX® | -0,44 % | -5,31 % | 1,44 % |
| iShares Nasdaq 100 | -0,19 % | 3,08 % | 18,68 % |
| iShares Nikkei 225® | -0,95 % | -5,88 % | 27,86 % |
| iShares S&P 500 | -0,42 % | 0,92 % | 13,17 % |
Comments by Barclays_PLC for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Barclays PLC from $148.00 to $90.00. They now have an "overweight" rating on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€8.12
07.11.25
07.11.25
€12.13
07.11.26
07.11.26
42.86%
18.03.26
18.03.26
Stopped prediction by Barclays_PLC for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.82
28.02.25
28.02.25
€25.05
28.02.26
28.02.26
11.87%
01.03.26
01.03.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€15.58
08.11.24
08.11.24
€51.38
08.11.25
08.11.25
-41.87%
09.11.25
09.11.25